Ironwood Financial, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Ironwood Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$543.48 - $670.97 $92,391 - $114,064	-170 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$574.03 - $680.96 $34,441 - $40,857	60 Added 54.55%	170 $103,000
Q1 2021 Apr 28, 2021	SELL	$446.73 - $548.2 $55,841 - $68,525	-125 Reduced 53.19%	110 $52,000
Q4 2020 Jan 26, 2021	BUY	$478.3 - $607.98 $16,740 - $21,279	35 Added 17.5%	235 $114,000
Q3 2018 Oct 26, 2018	BUY	$351.14 - $408.51 $70,228 - $81,702	200 New	200 $81,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.8B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Ironwood Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Ironwood Financial, LLC with notifications on news.